Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients
Introduction
Nephropathy and retinopathy are major microvascular complications of both type 1 and 2 diabetes mellitus and the most common causes of end stage renal disease and blindness, respectively. In addition to many risk factors such poor glycemic control [1] and hypertension [2], recent studies have shown that genetic factors may play a role in the development of diabetic microvascular complications, especially diabetic nephropathy. One of the candidate genes that may be associated with diabetic nephropathy in type 2 diabetes mellitus is the insertion/deletion (I/D) polymorphism in intron 16 of the angiotensin converting enzyme (ACE) gene. Plasma ACE levels are affected mainly by this polymorphism and subjects that are homozygous for the deletion (DD), heterozygous (I/D) and those that are homozygous for the insertion (I/I) have the highest, intermediate and lowest ACE plasma levels, respectively [3]. It has been known that ACE contributes to the regulation of systemic and renal hemodynamics by converting angiotensin I to angiotensin II [4], a potent vasoconstrictor that increases intraglomerular pressure and glomerular filtration [5]. Therefore, it has been suggested that an elevation of ACE plasma concentration may be associated with the microvascular complications of diabetes. This suggestion is supported by the fact that ACE inhibitors have a beneficial effect on the initiation and progression of diabetic nephropathy [6], [7], [8], [9]. However, controversial observations were reported in regard to the possible relationship of ACE I/D polymorphism and diabetic nephropathy and retinopathy in different ethnicities.
Therefore, the aim of the present study was to investigate whether an association exists between the ACE I/D polymorphism and microvascular complications of type 2 diabetes mellitus in Turkish patients.
Section snippets
Study population
A cross-sectional/case-control study was conducted in the Department of Internal Medicine, Hospital of Sahinbey, Gaziantep University, Turkey. Two hundred and thirty-nine (151 female, 88 male; mean age 53.2±8.9; aged between 31 and 70 years; mean duration of diabetes 8.4±6.6 years) type 2 diabetic patients were included into the study. No patient was on haemodialysis. Age and sex matched 138 (87 female, 51 male; mean age 51.5±9.3; aged between 29 and 68) control subjects without diabetes were
Clinical and laboratory characteristics in the patient group
Table 1 represents certain clinical and laboratory data in the patient group according to the ACE genotype. When laboratory values were compared among different genotypes of type 2 diabetic patients, no significant difference was detected with regard to age, sex, diabetes duration, BMI, systolic and diastolic blood pressure, HbA1c, serum triglyceride, total cholesterol, LDL-cholesterol or HDL-cholesterol (Table 1). However, patients with macroalbuminuria had longer diabetes duration, higher
Discussion
The development of diabetic nephropathy shows marked interethnic and inter-individual variation. Epidemiological studies showed a higher prevalence of diabetic nephropathy in non-whites than in whites [11], [12], [13]. In some diabetic patients, nephropathy develops in short-term disease duration, despite similar glycemic control and blood pressure among patients. On the other hand, in nearly all patients with type 1 diabetes mellitus, retinopathy develops with a long disease duration [14], [15]
Acknowledgements
This study was supported by a grant of the Research Foundation of University of Gaziantep, Turkey (Grant no. TF99-01).
References (50)
- et al.
Pathogenesis of diabetic microangiopathy; the hemodynamic view
Am. J. Med.
(1986) - et al.
UK Prospective Diabetes Study. XV: relationship of renin–angiotensin system gene polymorphisms with microalbuminuria in NIDDM
Kidney Int.
(1995) - et al.
Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy
Kidney Int.
(1997) - et al.
Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population
Metabolism
(1997) - et al.
Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group
Kidney Int.
(1995) - et al.
Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate
J. Diabetes Complicat.
(1995) - et al.
The angiotensin I-converting enzyme (ACE) locus is strongly associated with age and duration of diabetes in patients with type I diabetes
J. Diabetes Complicat.
(1997) - et al.
Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance
Am. J. Kidney Dis.
(1999) - et al.
Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics
Metabolism
(1996) - et al.
Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus
Kidney Int.
(1996)
Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes
Am. J. Kidney Dis.
Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension
Am. J. Hypertens.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus
New Engl. J. Med.
Relationship between blood pressure and urine albumin excretion in development of microalbuminuria
Diabetes
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
J. Clin. Invest.
Angiotensin I-converting enzyme and the changes in our concepts through the years
Hypertension
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria
Br. Med. J.
Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group
J. Am. Med. Assoc.
Renal protective effect of enalapril in diabetic nephropathy
Br. Med. J.
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group
New Engl. J. Med.
Incidence of end-stage renal failure in type II diabetes mellitus in Pima Indians
Diabetologia
Microalbuminuria in NIDDM: its prevalence in Indian compared with Europid patients
Br. Med. J.
Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM
Diabetes Care
The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years
Arch. Ophthalmol.
Cited by (34)
Angiotensin converting enzyme polymorphism in type 2 diabetes mellitus
2014, Biomarkers and Genomic MedicineCitation Excerpt :In respect to the patients within the cardiovascular disease risk group, a statistically significant difference was observed between the allelic and genotypic frequencies of ACE polymorphism when compared to patients and control groups. Some studies have revealed an association of the D allele with cardiovascular disease in Turkish, French, and Chinese populations.24–26 Zintzaras et al27 reported an association of the same allele with coronary artery disease in Caucasian and Turkish populations when the additive statistical model was used (D/D vs. I/I).
Angiotensin-converting enzyme gene polymorphism is correlated to diabetic retinopathy: a meta-analysis
2008, Journal of Diabetes and its ComplicationsCitation Excerpt :The ACE gene plays an important role in the regulation of the ACE (Araz et al., 2001). Because the renin/angiotensin system affects hemostasis through different mechanisms, data on the possible role of ACE insertion/deletion (I/D) polymorphism in the pathogenesis of thrombosis are interesting (Araz et al., 2001). For diabetes mellitus (DM), the clinical importance of ACE gene polymorphism is mentioned (Fujisawa et al., 1998).
A common variant in the ACE gene is associated with peripheral neuropathy in women with type 2 diabetes mellitus
2006, Journal of Diabetes and its ComplicationsThe D allele of the ACE I/D common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects
2005, Molecular Genetics and Metabolism